Abstract:Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach. Therapeutic recombinant proteins are a powerful tool for combating many diseases which have previously been hard to treat. The most utilized expression systems are Chinese Hamster Ovary cells and Escherichia coli, but all available expression systems have strengths and weaknesses regarding development time, cost, protein size, yield, growth conditions, posttranslational modifications and regulatory approval. The plant industry is well established and growing and harvesting crops is easy and affordable using current infrastructure. Growth conditions are generally simple: sunlight, water, and the addition of cheap, available fertilizers. There are multiple options for plant expression systems, including species, genetic constructs and protein targeting, each best suited to a particular type of therapeutic protein production. Transient expression systems provide a mechanism to rapidly transfect plants and produce therapeutic protein in a matter of weeks, rather than the months it can take for many competing expression systems, while proteins targeted to cereal seeds can be harvested, stored and potentially purified much more easily than in competing systems. Current challenges for plant expression systems include a lack of regulatory approval, environmental containment concerns and nonhuman glycosylation, which may limit the scope of the type of therapeutic proteins that can be manufactured in plants. The specific strengths of plant expression systems could facilitate the production of certain therapeutic proteins quickly and cheaply in the near future. Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach.

Cellular engineering of plant cells for improved therapeutic protein production

Maximizing the Production of Recombinant Proteins in Plants: from Transcription to Protein Stability

Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement

Therapeutic recombinant protein production in plants: Challenges and opportunities

Improving Protein Quantity and Quality-The Next Level of Plant Molecular Farming

Therapeutically important proteins from in vitro plant tissue culture systems

Gene delivery strategies for therapeutic proteins production in plants: Emerging opportunities and challenges

Advances on the Expressions of Foreign Proteins in Plants

Plant-based expression platforms to produce high-value metabolites and proteins

Plant glycoengineering for designing next-generation vaccines and therapeutic proteins

Progress Of Transgenic Plant As Bioreactor For Pharmaceutical Proteins

The advent of plant cells in bioreactors

Plant-based biopharmaceutical engineering

Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead

The production of biopharmaceuticals in plant systems

Review of Recombinant Therapeutic Protein Expression in Transgenic Plants

Improvement of phytochemical production by plant cells and organ culture and by genetic engineering

Ultrasound-driven nanosilicon transfected tobacco cell as robust factory for collagen III protein synthesis

Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems

Green biofactories: recombinant protein production in plants

Progress in Transgenic Plants Producing Pharmaceutical Proteins